Mahsa Ahadi

1.3k total citations
26 papers, 445 citations indexed

About

Mahsa Ahadi is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Mahsa Ahadi has authored 26 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Surgery and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Mahsa Ahadi's work include Genetic factors in colorectal cancer (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Mahsa Ahadi is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Mahsa Ahadi collaborates with scholars based in Australia, Iran and United States. Mahsa Ahadi's co-authors include Anthony J. Gill, Angela Chou, Amy Sheen, Loretta Sioson, Talia L. Fuchs, Juliana Andrici, Adele Clarkson, Anna Sokolova, Ian Brown and Mahtab Farzin and has published in prestigious journals such as Annals of Surgery, The American Journal of Surgical Pathology and Human Pathology.

In The Last Decade

Mahsa Ahadi

26 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahsa Ahadi Australia 10 238 176 107 106 99 26 445
Douglas Webber Canada 10 284 1.2× 217 1.2× 107 1.0× 125 1.2× 96 1.0× 25 495
Junichi Tomomatsu Japan 13 232 1.0× 158 0.9× 61 0.6× 48 0.5× 106 1.1× 49 431
Seog Yun Park South Korea 11 163 0.7× 133 0.8× 161 1.5× 81 0.8× 53 0.5× 27 408
Anja Foerster Switzerland 9 218 0.9× 192 1.1× 96 0.9× 173 1.6× 128 1.3× 12 491
Öznur Bal Türkiye 12 175 0.7× 142 0.8× 60 0.6× 76 0.7× 78 0.8× 49 380
Christopher DiSimone United States 6 271 1.1× 148 0.8× 71 0.7× 60 0.6× 114 1.2× 10 490
Aurélie Ferru France 11 250 1.1× 82 0.5× 39 0.4× 84 0.8× 93 0.9× 30 439
A. De Jesus Acosta United States 6 327 1.4× 133 0.8× 123 1.1× 162 1.5× 76 0.8× 10 572
Laura Belvederesi Italy 12 210 0.9× 116 0.7× 55 0.5× 143 1.3× 125 1.3× 29 467
Chenghao Yi China 9 216 0.9× 64 0.4× 91 0.9× 133 1.3× 83 0.8× 16 362

Countries citing papers authored by Mahsa Ahadi

Since Specialization
Citations

This map shows the geographic impact of Mahsa Ahadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahsa Ahadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahsa Ahadi more than expected).

Fields of papers citing papers by Mahsa Ahadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahsa Ahadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahsa Ahadi. The network helps show where Mahsa Ahadi may publish in the future.

Co-authorship network of co-authors of Mahsa Ahadi

This figure shows the co-authorship network connecting the top 25 collaborators of Mahsa Ahadi. A scholar is included among the top collaborators of Mahsa Ahadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahsa Ahadi. Mahsa Ahadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sahni, Sumit, Christopher B. Nahm, Mahsa Ahadi, et al.. (2023). Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy. Cancer Medicine. 12(17). 18050–18061. 4 indexed citations
2.
Aksoy, Yagiz Alp, Angela Chou, Amy Sheen, et al.. (2023). A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma. Pathology. 55(4). 449–455. 2 indexed citations
3.
Fuchs, Talia L., Catherine Luxford, Adele Clarkson, et al.. (2022). A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma. The American Journal of Surgical Pathology. 47(1). 25–36. 11 indexed citations
4.
Rakhsha, Afshin, et al.. (2022). Successful Treatment of Central Nervous System Histiocytic Sarcoma With Craniectomy and Adjuvant Radiotherapy. Cureus. 14(5). e24690–e24690. 4 indexed citations
5.
Fuchs, Talia L., Angela Chou, Loretta Sioson, et al.. (2022). What are the problems with the current staging of discontinuous tumour nodules (DTNs) in colorectal carcinoma? Is there a better way?. Pathology. 54(7). 848–854. 2 indexed citations
7.
Jamali, Elena, et al.. (2022). Quantity and Distribution of Eosinophils in Esophageal Specimens of Adults: An Iranian Population-Based Study. Iranian journal of pathology. 17(2). 136–142. 2 indexed citations
8.
Ahadi, Mahsa, et al.. (2021). Is corona virus infection a risk factor for hematuria in secondary bladder amyloidosis? The first case report. Urology Case Reports. 38. 101642–101642. 3 indexed citations
11.
Ahadi, Mahsa, et al.. (2021). The Anatomy of Nerve Transfers Used in Tetraplegic Hand Reconstruction. The Journal Of Hand Surgery. 47(11). 1121.e1–1121.e6. 6 indexed citations
12.
Ahadi, Mahsa, Anna Sokolova, Ian Brown, Angela Chou, & Anthony J. Gill. (2021). The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment. Pathology. 53(4). 454–461. 71 indexed citations
13.
Li, Jun, et al.. (2021). Molecular Features of Lymph Node Metastasis in T1/2 Colorectal Cancer from Formalin-Fixed Paraffin-Embedded Archival Specimens. Journal of Proteome Research. 20(2). 1304–1312. 12 indexed citations
14.
Ahadi, Mahsa, Anthony J. Gill, Samar M. Said, et al.. (2020). SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. The American Journal of Surgical Pathology. 45(3). 414–420. 30 indexed citations
15.
Sahni, Sumit, Viive M. Howell, Shreya Mehta, et al.. (2020). Tissue biomarker panel as a surrogate marker for squamous subtype of pancreatic cancer. European Journal of Surgical Oncology. 46(8). 1539–1542. 7 indexed citations
16.
Chou, Angela, Mahsa Ahadi, Talia L. Fuchs, et al.. (2019). NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases. Modern Pathology. 33(5). 924–932. 46 indexed citations
17.
Hedayati, Mehdi, et al.. (2017). Plasma Calcitonin Levels and miRNA323 Expression in Medullary Thyroid Carcinoma Patients with or without RET Mutation. PubMed. 18(8). 2179–2184. 5 indexed citations
18.
Ahadi, Mahsa, Juliana Andrici, Loretta Sioson, et al.. (2016). Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma. Human Pathology. 57. 91–97. 16 indexed citations
19.
Andrici, Juliana, Amy Sheen, Loretta Sioson, et al.. (2015). Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Modern Pathology. 28(10). 1360–1368. 74 indexed citations
20.
Ahadi, Mahsa, et al.. (2015). Primary Neuroendocrine Tumor of Liver (Rare Tumor of Liver). Iranian Journal of Cancer Prevention. 8(6). e3144–e3144. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026